Plasmablastic Lymphoma. A State-of-the-Art Review: Part 2-Focus on Therapy.

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Plasmablastic lymphoma is an aggressive non-Hodgkin lymphoma, often associated with HIV.
• Previous review parts covered epidemiology, etiology, and diagnosis.
• Management remains challenging due to its aggressive nature.

Purpose of the Study:

• To provide a comprehensive overview of plasmablastic lymphoma treatment.
• To examine conventional and novel therapeutic strategies.
• To update current understanding of managing plasmablastic lymphoma.

Main Methods:

• Literature review of existing studies on plasmablastic lymphoma treatment.
• Analysis of conventional treatment protocols.
• Evaluation of emerging therapeutic approaches and clinical trials.

Main Results:

• Conventional treatments include chemotherapy regimens like dose-adjusted EPOCH-R.
• Novel strategies involve targeted therapies and immunotherapy.
• Treatment outcomes vary significantly based on patient factors and chosen therapy.

Conclusions:

• Optimizing plasmablastic lymphoma treatment requires a tailored approach.
• Further research into novel therapies is crucial for improving patient survival.
• Multidisciplinary care is essential for effective management.